![Hans Thorleif Moller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hans Thorleif Moller
Founder at Ranger Biotechnologies A/S
Hans Thorleif Moller active positions
Companies | Position | Start | End |
---|---|---|---|
Ranger Biotechnologies A/S
![]() Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Director/Board Member | 30/11/2009 | - |
Chief Executive Officer | 30/11/2009 | - | |
Founder | 30/06/2009 | - |
Career history of Hans Thorleif Moller
Former positions of Hans Thorleif Moller
Companies | Position | Start | End |
---|---|---|---|
CEM Innovation A/S
![]() CEM Innovation A/S Construction MaterialsNon-Energy Minerals CEM Innovation A/S develops and supplies cement products. The firm's products are used in the engineering, construction, and other industries. The company is headquartered in Sonderso, Denmark. | Corporate Officer/Principal | - | 17/03/2011 |
Profylakse ApS
![]() Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations. | Founder | 01/01/1999 | - |
Statistics
International
Denmark | 4 |
Operational
Founder | 2 |
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
Sectoral
Non-Energy Minerals | 2 |
Health Technology | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
CEM Innovation A/S
![]() CEM Innovation A/S Construction MaterialsNon-Energy Minerals CEM Innovation A/S develops and supplies cement products. The firm's products are used in the engineering, construction, and other industries. The company is headquartered in Sonderso, Denmark. | Non-Energy Minerals |
Profylakse ApS
![]() Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations. | Health Technology |
Ranger Biotechnologies A/S
![]() Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Commercial Services |
- Stock Market
- Insiders
- Hans Thorleif Moller
- Experience